Clinical Trial Update: RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine [Phase 2, Phase 3]

View source ↗

Summary

The RECLAIM trial evaluating adaptive integrative medicine for lingering COVID-19 symptoms has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: University Health Network, Toronto | Conditions: Long COVID, Post COVID Condition | Phase 2, Phase 3 | Status: COMPLETED